The study aims to establish if it is possible for people with Cystic Fibrosis to monitor a number of parameters on a daily basis at home which might predict respiratory infections before they have symptoms and which might also predict treatment failures before this is obvious with conventional measures.
Participants will collect the following clinical information daily: pulse rate and oxygen saturations, wellness and cough scores, spirometry measurements, physical activity, temperature, weight and sleep quantity and quality. The patients will also collect daily sputum samples. Data will be collected via Bluetooth-enabled devices and transmitted via a Smart-phone to a secure National Health Service approved web-based site to be analyzed. The information obtained will allow the investigators to develop a software program that will identify signals that can predict the onset of a chest infection before symptoms develop. The investigators will also measure specific substances in sputum to identify changes before, during and after chest infections. The investigators hope this additional information will enable them to more accurately predict the onset of chest infections in cystic fibrosis. The results of this study will determine if it is possible to develop a simple sputum test for patients to use at home in combination with other home-based assessments of well-being to provide an early warning system of a chest infection before patients feel unwell.
Study Type
OBSERVATIONAL
Enrollment
147
Papworth Hospital NHS Trust
Cambridge, Cambridgeshire, United Kingdom
Papworth Hospital NHS Trust
Cambridge, United Kingdom
Home monitoring possible in adult Cystic Fibrosis patients
This will be measured by the number of patients recruited into the study and the patients compliance / adherence to the study protocol
Time frame: 6 months
Whether daily monitoring can provide early warning of a new chest infection
Identification of predictive signals for early detection of an acute pulmonary exacerbations and treatment response in patients with cystic fibrosis
Time frame: 6 months
Development of a web-based machine learning tool
Development of a web-based machine learning associated tool to predict acute pulmonary exacerbation and treatment response in patients with cystic fibrosis.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.